HUT37805A - Process for production of new insuline derivatives and medical preparatives containing them - Google Patents

Process for production of new insuline derivatives and medical preparatives containing them

Info

Publication number
HUT37805A
HUT37805A HU842766A HU276684A HUT37805A HU T37805 A HUT37805 A HU T37805A HU 842766 A HU842766 A HU 842766A HU 276684 A HU276684 A HU 276684A HU T37805 A HUT37805 A HU T37805A
Authority
HU
Hungary
Prior art keywords
new
production
preparatives containing
insuline
derivatives
Prior art date
Application number
HU842766A
Other languages
English (en)
Inventor
Ulrich Grau
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of HUT37805A publication Critical patent/HUT37805A/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/622Insulins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU842766A 1983-07-22 1984-07-16 Process for production of new insuline derivatives and medical preparatives containing them HUT37805A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833326472 DE3326472A1 (de) 1983-07-22 1983-07-22 Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus

Publications (1)

Publication Number Publication Date
HUT37805A true HUT37805A (en) 1986-02-28

Family

ID=6204660

Family Applications (1)

Application Number Title Priority Date Filing Date
HU842766A HUT37805A (en) 1983-07-22 1984-07-16 Process for production of new insuline derivatives and medical preparatives containing them

Country Status (20)

Country Link
US (1) US4701440A (hu)
EP (1) EP0132770B1 (hu)
JP (2) JPS6042397A (hu)
AR (1) AR241864A1 (hu)
AT (1) ATE29729T1 (hu)
AU (1) AU569097B2 (hu)
CA (1) CA1246548A (hu)
DE (2) DE3326472A1 (hu)
DK (2) DK172211B1 (hu)
ES (2) ES534487A0 (hu)
FI (1) FI79854C (hu)
GR (1) GR81551B (hu)
HU (1) HUT37805A (hu)
IE (1) IE57709B1 (hu)
IL (1) IL72469A (hu)
NO (1) NO167810C (hu)
NZ (1) NZ208959A (hu)
PH (1) PH23014A (hu)
PT (1) PT78940A (hu)
ZA (1) ZA845620B (hu)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3327928A1 (de) * 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
DK113585D0 (da) * 1985-03-12 1985-03-12 Novo Industri As Nye peptider
US4946828A (en) * 1985-03-12 1990-08-07 Novo Nordisk A/S Novel insulin peptides
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
DE3717370A1 (de) * 1987-05-22 1988-12-01 Hoechst Ag Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
DE3827533A1 (de) * 1988-08-13 1990-02-15 Hoechst Ag Pharmazeutische zubereitung zur behandlung des diabetes mellitus
DE3837825A1 (de) * 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
HUT56857A (en) * 1988-12-23 1991-10-28 Novo Nordisk As Human insulin analogues
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
DE3936876A1 (de) * 1989-11-06 1991-05-23 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
WO1992010284A2 (en) 1990-12-07 1992-06-25 Cnc Development, Inc. Catalytic chemical reactor
YU66892A (sh) * 1991-08-20 1995-10-24 Hoechst Ag. Fosfoinositolglikan - peptid sa delovanjem kao insulin
CZ342492A3 (en) * 1991-11-26 1993-06-16 Lilly Co Eli Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised
DE59209745D1 (de) * 1991-11-29 1999-10-21 Hoechst Ag Peptide mit insulinartiger Wirkung
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
ATE264871T1 (de) 1996-07-26 2004-05-15 Aventis Pharma Gmbh Insulinderivate mit erhöhter zinkbindung
DE19649350A1 (de) * 1996-11-28 1998-06-04 Hoechst Ag Inositolglykane mit insulinartiger Wirkung
US6444641B1 (en) 1997-10-24 2002-09-03 Eli Lilly Company Fatty acid-acylated insulin analogs
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
JP4969002B2 (ja) 1999-06-08 2012-07-04 ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン rAAV形質導入を増加するための化合物および方法
AU2002248464A1 (en) 2001-02-21 2002-09-12 Medtronic Minimed, Inc. Stabilized insulin formulations
EP1378492B1 (en) * 2001-02-21 2008-04-02 Seiwa Pro Co., Ltd. Remover for scale deposited on titanium material
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
CA2520028A1 (en) 2003-03-31 2004-10-21 University Of Iowa Research Foundation Compounds and methods to enhance raav transduction
JP2008500006A (ja) * 2003-05-21 2008-01-10 バイオテック トゥールス ソシエテ アノニム ペプチド複合体
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
KR101939557B1 (ko) 2008-10-17 2019-01-17 사노피-아벤티스 도이칠란트 게엠베하 인슐린과 glp-1 효능제의 병용물
CN107308442B (zh) 2009-11-13 2022-10-18 赛诺菲-安万特德国有限公司 包含glp-1激动剂、胰岛素和甲硫氨酸的药物组合物
PT3345593T (pt) 2009-11-13 2023-11-27 Sanofi Aventis Deutschland Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina
LT2611458T (lt) 2010-08-30 2016-12-27 Sanofi-Aventis Deutschland Gmbh Ave0010 panaudojimas gaminant vaistą, skirtą 2 tipo cukrinio diabeto gydymui
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
MX370264B (es) 2011-08-29 2019-12-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2.
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
SI3229828T1 (sl) 2014-12-12 2023-06-30 Sanofi-Aventis Deutschland Gmbh Formulacija s fiksnim razmerjem inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
US11702672B2 (en) 2016-02-08 2023-07-18 University Of Iowa Research Foundation Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
US11684679B2 (en) 2016-03-07 2023-06-27 University Of Iowa Research Foundation AAV-mediated expression using a synthetic promoter and enhancer
WO2020058322A1 (en) 2018-09-19 2020-03-26 Ziylo Ltd. Glucose sensitive insulins and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2256215C3 (de) * 1972-11-16 1981-01-08 Hoechst Ag, 6000 Frankfurt Insulin-Zubereitung mit einem Gehalt an kristallinem Insulin und amorphem Desphenylalanin8' -insulin
DE2460753A1 (de) * 1974-12-21 1976-06-24 Hoechst Ag Verfahren zur herstellung von humaninsulin
NO153061C (no) * 1979-04-13 1986-01-08 Shionogi & Co Fremgangsmaate for fremstilling av et b30-threonininsulin
DK319780A (da) * 1980-07-24 1982-01-25 Forenede Bryggerier As Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner
DE3209184A1 (de) * 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen
NL8201650A (nl) * 1982-04-21 1983-11-16 Akzo Nv Semisynthetische bereiding van humane insuline.
DE3327928A1 (de) * 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DE3334407A1 (de) * 1983-09-23 1985-04-04 Hoechst Ag, 6230 Frankfurt In position b 30 modifizierte insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
JPH118546A (ja) * 1997-04-24 1999-01-12 Hitachi Ltd Cmos回路

Also Published As

Publication number Publication date
GR81551B (hu) 1984-12-11
NO842977L (no) 1985-01-23
AU3092284A (en) 1985-01-24
AU569097B2 (en) 1988-01-21
ES535706A0 (es) 1985-06-01
DE3466227D1 (en) 1987-10-22
NZ208959A (en) 1989-02-24
US4701440A (en) 1987-10-20
ES8505646A1 (es) 1985-06-01
DK172211B1 (da) 1998-01-05
EP0132770B1 (de) 1987-09-16
JPH0357119B2 (hu) 1991-08-30
PH23014A (en) 1989-03-03
FI842914A (fi) 1985-01-23
DK358284A (da) 1985-01-23
FI842914A0 (fi) 1984-07-19
IE57709B1 (en) 1993-03-10
IL72469A0 (en) 1984-11-30
IE841889L (en) 1985-01-22
ATE29729T1 (de) 1987-10-15
DK358284D0 (da) 1984-07-20
DK1790A (da) 1990-01-04
IL72469A (en) 1989-07-31
FI79854C (fi) 1990-03-12
DE3326472A1 (de) 1985-02-14
FI79854B (fi) 1989-11-30
NO167810B (no) 1991-09-02
DK1790D0 (da) 1990-01-04
ES8504678A1 (es) 1985-04-16
EP0132770A1 (de) 1985-02-13
PT78940A (de) 1984-08-01
NO167810C (no) 1991-12-18
ES534487A0 (es) 1985-04-16
AR241864A1 (es) 1993-01-29
JPH052654B2 (hu) 1993-01-13
JPS6042397A (ja) 1985-03-06
CA1246548A (en) 1988-12-13
ZA845620B (en) 1985-02-27
DK172209B1 (da) 1998-01-05
JPH01294634A (ja) 1989-11-28

Similar Documents

Publication Publication Date Title
HUT37805A (en) Process for production of new insuline derivatives and medical preparatives containing them
HUT40759A (en) Process for production of medical preparatives containing derivatives of antracyclin-glycosid
HUT38265A (en) Process for production of new esthers and compositions containing thereof
HUT36834A (en) Process for production of hialuron-acid fractions and medical preparatives consisting of them
HUT45270A (en) Process for production of polipeptides containing nor-statine and nor-cyclostatin
HUT37619A (en) Process for production of new ganine derivatives
HUT44794A (en) Process for production of calcitonine-derivatives and medical preparatives containing such compounds
HUT37628A (en) Process for production of acetil-eritromicin-stearat and medical preparatives containing - as reagent - such compounds
HUT37618A (en) Process for production of new 2-phenil imadosoles
HUT35248A (en) Process for production of phenil-kinolin-carbonic acids and medical preparatives consisting of such compounds
HUT36119A (en) Process for production of pirido-4,3-g-indole derivatives and medical preparatives consisting of such compounds
YU43390B (en) Process for preparation of new phenolsulphonphtaleinyle-beta-d-galactosides
YU14184A (en) Process for making new derivatives of cyano-4-pyridiazine
HUT37355A (en) Process for production of plaster-formed medical preparatives
HUT36089A (en) Process for production of new aminoguanidin derivatives
HUT44483A (en) Process for production of derivatives of 2n (benzolsulphonil)-antranil-acid-amid and medical preparatives containing them
YU135884A (en) Process for making derivatives of piperidino-hynazoline
HUT36793A (en) Process for producing new spirosuccunimide derivatives and pharmaceutical composition containing them
HUT40430A (en) Process for production of new derivatives of kynolin-carbonic acid and medical preparatives containing thereof
HUT37763A (en) Process for production of new benzimidazols
HUT36090A (en) Process for production of 16-phenoxi- and 16-substituated phenoxi-carbonic-acid derivatives and medical preperatives consosting of such compounds
HUT37342A (en) Process for production of preparatives for medical cosmetics
HUT35263A (en) Process for production of 2-mercapto-piramido-hexahydrokinolin derivatives
HUT36107A (en) Process for production of new aurone-derivatives and medical preparatives consisting of such compounds
HUT38646A (en) Process for production of derivatives of spirohydantion and preparatives containing thereof